Dr. Agarwal's Health Care Limited (AGARWALEYE) Earnings Call Transcripts

Dr. Agarwal's Health Care Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Dr. Agarwal's Healthcare Limited reported a total income of INR 577 crores, reflecting a 21.2% year-on-year increase, while revenue from operations reached INR 564 crores, up 22.6% YoY. For the full fiscal year, total income was INR 2,125 crores, a 20.9% increase, with revenue from operations at INR 2,080 crores, up 21.6%. Management maintained guidance for sustained growth in FY '27, expecting similar revenue growth driven by expansion and operational efficiencies.

Reported metrics

Guidance from management

Management expects growth to sustain at a similar pace in FY '27, driven by deeper penetration of existing micro markets and expansion into new geographies. They anticipate stable EBITDA margins despite aggressive investments in greenfield expansion.

What management said

So for this year, we are looking at an overall outflow of about INR 380 crores to INR 400 crores, which includes all our CapEx for this year, including our new CMS facility. We're looking at adding about 40 surgical facilities and 20 clinics, and this would envisage a total CapEx spend of about INR 380 crores to INR 400 crores. And this includes the CapEx spend for our new CMS facility.

Tushar, this is Rahul. We have added one tertiary facility last year. In this year, we are looking at adding one more tertiary facility in West. In fact, we've just started that facility in Thane, which we are calling the Thane Main Hospital. And that's a facility which is having all the technology, and we're just in the first few days of launch.

What analysts pressed on

Analysts expressed concerns regarding the impact of new facility openings on margins, particularly with a reported loss of INR 30 crores from new branches opened in FY '26. There were also questions about the sustainability of same-store sales growth and potential challenges in maintaining operational efficiencies amid rapid expansion.

Main topics on the call

• Strong Revenue Growth — The company achieved a total income of INR 2,125 crores for FY '26, up 20.9% YoY, with revenue from operations increasing by 21.6% to INR 2,080 crores. Management noted, "For the first time in our company's history, we c...
• Expansion of Facilities — Dr. Agarwal's Healthcare opened 19 new facilities in Q4 FY '26, contributing to a total of 269 facilities across India and Africa. The company plans to add 60 new facilities in FY '27, including 40 surgical centers and 2...
• Improved Profitability — The profit after tax for FY '26 grew by 52.4% YoY to INR 168 crores, with a PAT margin of 7.9%. Management highlighted, "We delivered a robust Ind AS EBITDA of INR 614 crores, reflecting a 22.2% year-on-year growth."
• Same-Store Sales Growth — Same-store sales growth for mature facilities was reported at 14%, contributing significantly to overall revenue. Management stated, "Facilities opened in FY '23 delivered INR 257 crores, growing at 14%."

Read the full Dr. Agarwal's Health Care Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 5 Dr. Agarwal's Health Care Limited earnings call transcripts on record, spanning August 12, 2025 to August 4, 2026. Based on this history, Dr. Agarwal's Health Care Limited reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

AGARWALEYE

Exchange

NSEI

Country

IN

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

5

First call

August 12, 2025

Most recent

August 4, 2026

Reporting cadence

quarterly